Literature DB >> 25819093

Synthesis of [(11)C]GSK1482160 as a new PET agent for targeting P2X(7) receptor.

Mingzhang Gao1, Min Wang1, Mark A Green1, Gary D Hutchins1, Qi-Huang Zheng2.   

Abstract

The authentic standards GSK1482160 and its isomer, as well as the radiolabeling precursors desmethyl-GSK1482160 and Boc-protected desmethyl-GSK1482160 were synthesized from L-pyroglutamic acid, methyl L-pyroglutamate and 2-chloro-3-(trifluoromethyl)benzylamine with overall chemical yield 27-28% in 3 steps, 58% in 4 steps, 76% in 1 step and 33% in 2 steps, respectively. [(11)C]GSK1482160 was prepared from either desmethyl-GSK1482160 or Boc-protected desmethyl-GSK1482160 with [(11)C]CH3OTf through N-[(11)C]methylation and isolated by HPLC combined with SPE in 40-50% and 30-40% radiochemical yield, respectively, based on [(11)C]CO2 and decay corrected to end of bombardment (EOB). The radiochemical purity was >99%, and the specific activity at EOB was 370-1110 GBq/μmol with a total synthesis time of ∼40-min from EOB.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Neuroinflammation; P2X(7) receptor; Positron emission tomography (PET); Radiosynthesis; [(11)C]GSK1482160

Mesh:

Substances:

Year:  2015        PMID: 25819093     DOI: 10.1016/j.bmcl.2015.03.021

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  16 in total

Review 1.  Medicinal chemistry of adenosine, P2Y and P2X receptors.

Authors:  Kenneth A Jacobson; Christa E Müller
Journal:  Neuropharmacology       Date:  2015-12-12       Impact factor: 5.250

2.  Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response.

Authors:  Junbin Han; Hui Liu; Chunling Liu; Hongjun Jin; Joel S Perlmutter; Terrance M Egan; Zhude Tu
Journal:  Nucl Med Commun       Date:  2017-05       Impact factor: 1.690

3.  Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease.

Authors:  Hongjun Jin; Junbin Han; Derek Resing; Hui Liu; Xuyi Yue; Rebecca L Miller; Kathleen M Schoch; Timothy M Miller; Joel S Perlmutter; Terrance M Egan; Zhude Tu
Journal:  Eur J Pharmacol       Date:  2017-12-07       Impact factor: 4.432

4.  PET Imaging of the P2X7 Ion Channel with a Novel Tracer [18F]JNJ-64413739 in a Rat Model of Neuroinflammation.

Authors:  Tamara Berdyyeva; Chunfang Xia; Natalie Taylor; Yingbo He; Gang Chen; Chaofeng Huang; Wei Zhang; Hartmuth Kolb; Michael Letavic; Anindya Bhattacharya; Anna Katrin Szardenings
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

5.  [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson's disease and healthy volunteers.

Authors:  Donatienne Van Weehaeghe; Michel Koole; Mark E Schmidt; Stephanie Deman; Andreas H Jacobs; Erika Souche; Kim Serdons; Stefan Sunaert; Guy Bormans; Wim Vandenberghe; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-26       Impact factor: 9.236

6.  Agonists, Antagonists, and Modulators of P2X7 Receptors.

Authors:  Christa E Müller; Vigneshwaran Namasivayam
Journal:  Methods Mol Biol       Date:  2022

Review 7.  Role of neuro-immunological factors in the pathophysiology of mood disorders.

Authors:  Anindya Bhattacharya; Noel C Derecki; Timothy W Lovenberg; Wayne C Drevets
Journal:  Psychopharmacology (Berl)       Date:  2016-01-23       Impact factor: 4.530

8.  Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7.

Authors:  Enrico Raffaele Fantoni; Diego Dal Ben; Simonetta Falzoni; Francesco Di Virgilio; Simon Lovestone; Antony Gee
Journal:  EJNMMI Res       Date:  2017-04-04       Impact factor: 3.138

Review 9.  Purinergic Receptors: Key Mediators of HIV-1 Infection and Inflammation.

Authors:  Talia H Swartz; George R Dubyak; Benjamin K Chen
Journal:  Front Immunol       Date:  2015-11-26       Impact factor: 7.561

Review 10.  Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes.

Authors:  Pekka Poutiainen; Merja Jaronen; Francisco J Quintana; Anna-Liisa Brownell
Journal:  Front Mol Neurosci       Date:  2016-09-15       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.